Global biotechnology company, Shire, has filed its first submission to the US Food and Drug Administration (FDA) for a new plasma manufacturing facility in Covington, Georgia, to support growth in its immunology franchise.
Original Article: Shire files first submission to FDA for new plasma manufacturing facility
NEXT ARTICLE